VACCINE DIRECTED AGAINST ADENOVIRUS SEROTYPE 14

The invention is directed to a live attenuated serotype 14 adenovirus, and a method of inducing an immune response against a serotype 14 adenovirus in a mammal using the live attenuated serotype 14 adenovirus.

Saved in:
Bibliographic Details
Main Authors KAHL, CHRISTOPH, GALL, JASON, G. D, NABEL, GARY, J
Format Patent
LanguageEnglish
French
German
Published 06.10.2010
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The invention is directed to a live attenuated serotype 14 adenovirus, and a method of inducing an immune response against a serotype 14 adenovirus in a mammal using the live attenuated serotype 14 adenovirus.
Bibliography:Application Number: EP20080859440